DK2058328T3 - Derivater af biologisk aktivt peptid VAPEEHPTLLTEAPLNPK - Google Patents

Derivater af biologisk aktivt peptid VAPEEHPTLLTEAPLNPK

Info

Publication number
DK2058328T3
DK2058328T3 DK09002378.9T DK09002378T DK2058328T3 DK 2058328 T3 DK2058328 T3 DK 2058328T3 DK 09002378 T DK09002378 T DK 09002378T DK 2058328 T3 DK2058328 T3 DK 2058328T3
Authority
DK
Denmark
Prior art keywords
peptide
vapeehptllteaplnpk
biologically active
active peptide
peptide derivatives
Prior art date
Application number
DK09002378.9T
Other languages
English (en)
Inventor
Wai Ming Wong
Kong Lam
Original Assignee
Cms Peptides Patent Holding Company Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cms Peptides Patent Holding Company Ltd filed Critical Cms Peptides Patent Holding Company Ltd
Application granted granted Critical
Publication of DK2058328T3 publication Critical patent/DK2058328T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4716—Muscle proteins, e.g. myosin, actin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK09002378.9T 2004-04-28 2005-04-25 Derivater af biologisk aktivt peptid VAPEEHPTLLTEAPLNPK DK2058328T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56645504P 2004-04-28 2004-04-28
EP05743126A EP1756152A2 (en) 2004-04-28 2005-04-25 Biologically active peptide vapeehptllteaplnpk derivatives

Publications (1)

Publication Number Publication Date
DK2058328T3 true DK2058328T3 (da) 2011-06-27

Family

ID=34967983

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09002378.9T DK2058328T3 (da) 2004-04-28 2005-04-25 Derivater af biologisk aktivt peptid VAPEEHPTLLTEAPLNPK

Country Status (18)

Country Link
US (1) US7718764B2 (da)
EP (2) EP1756152A2 (da)
JP (1) JP4689664B2 (da)
KR (1) KR101323771B1 (da)
CN (1) CN1976947B (da)
AT (1) ATE505483T1 (da)
AU (1) AU2005238173B2 (da)
CA (1) CA2564179C (da)
DE (1) DE602005027502D1 (da)
DK (1) DK2058328T3 (da)
ES (1) ES2365084T3 (da)
HK (1) HK1126790A1 (da)
NZ (1) NZ551595A (da)
PT (1) PT2058328E (da)
RU (1) RU2377249C2 (da)
TW (1) TWI353252B (da)
WO (1) WO2005105832A2 (da)
ZA (1) ZA200608865B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018105550A1 (ja) * 2016-12-05 2018-06-14 大塚製薬株式会社 筋萎縮抑制組成物
WO2021108916A1 (en) * 2019-12-06 2021-06-10 Cooke Aquaculture Inc. Peptides for regulating glucose
CN112812171B (zh) * 2021-01-22 2022-04-08 浙江辉肽生命健康科技有限公司 具有氨基酸结构vvrkplnkegkkp的生物活性肽及其制备方法和应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242821A (en) 1989-07-10 1993-09-07 Valio, Finnish Co-Operative Dairies' Association Lactococcus promoter and signal sequences for expression in bacteria
IT1231156B (it) 1989-07-19 1991-11-19 Eniricerche Spa Espressione e secrezione di interleuchina 1 beta umana matura in bacillus subtilis e mezzi e metodi per il suo ottenimento.
DE69433299T2 (de) 1993-06-15 2004-09-09 E.I. Du Pont De Nemours And Co., Wilmington Rekombinante spinnerseide analoge
JP3286420B2 (ja) 1993-09-28 2002-05-27 株式会社ユニシアジェックス 内燃機関の吸排気弁駆動制御装置
WO1995035389A1 (en) 1994-06-17 1995-12-28 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Method for introduction of genetic material into microorganisms and transformants obtained therewith
US6184208B1 (en) 1994-06-29 2001-02-06 Immunotech Developments Inc. Peptide, a method for its preparation and a pharmaceutical composition containing the peptide
IL115199A (en) 1995-09-07 2005-05-17 Opperbas Holding Bv Composition comprising a polynucleic acid molecule in a liposome and method using said composition
EP0867450B1 (en) 1995-10-24 2004-08-11 Juridical Foundation, The Chemo-Sero-Therapeutic Research Institute TFPI-related Peptides which inhibit growth of smooth muscle cells
GB9710762D0 (en) * 1997-05-23 1997-07-23 Cancer Res Inst Royal Binding complexes
DE69732378D1 (de) 1997-05-27 2005-03-03 Hanil Synthetic Fiber Co Ltd Verfahren zur herstellung von rekombinanten eiweissen durch verwendung von hocheffizienten expressionsvektoren aus saccharomyces cerevisiae
KR19990024297A (ko) 1997-08-07 1999-04-06 오종석 인체 구강내 치태형성을 억제하는 신규한 유산균
US6100388A (en) 1998-03-16 2000-08-08 Biogaia Biologies Ab Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
US6562958B1 (en) * 1998-06-09 2003-05-13 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Acinetobacter baumannii for diagnostics and therapeutics
US6245427B1 (en) 1998-07-06 2001-06-12 DüZGüNES NEJAT Non-ligand polypeptide and liposome complexes as intracellular delivery vehicles
US20040214184A1 (en) * 2001-02-28 2004-10-28 Skubitz Keith M Small peptides capable of modulating the function of cd66 (ceacam) family members
DE10133576A1 (de) * 2001-07-13 2003-01-30 Martin Klingmueller Verwendung von physiologisch aktiven Oligopeptiden zur Stabilisierung des Immunsystems
ES2345842T3 (es) * 2001-07-13 2010-10-04 Cms Peptides Patent Holding Company Limited Peptidos biologicamente activos.
CN1210295C (zh) 2001-07-13 2005-07-13 一泰医药研究（深圳）有限公司 序列号24的生物活性肽
JPWO2004055045A1 (ja) * 2002-12-16 2006-04-20 株式会社シーエーエフラボラトリーズ サルモネラ抗原処方物、それを使用した抗体検査キット及びサブユニットワクチン
WO2004055042A1 (en) * 2002-12-18 2004-07-01 Pepharm R & D Limited Biologically active peptide conjugates

Also Published As

Publication number Publication date
US7718764B2 (en) 2010-05-18
EP2058328B1 (en) 2011-04-13
HK1126790A1 (en) 2009-09-11
KR101323771B1 (ko) 2013-10-29
CN1976947A (zh) 2007-06-06
JP2008501642A (ja) 2008-01-24
ZA200608865B (en) 2009-06-24
NZ551595A (en) 2010-04-30
RU2006137699A (ru) 2008-04-27
EP1756152A2 (en) 2007-02-28
US20080125372A1 (en) 2008-05-29
TW200538151A (en) 2005-12-01
CA2564179C (en) 2013-08-06
CN1976947B (zh) 2010-05-05
WO2005105832A2 (en) 2005-11-10
AU2005238173A1 (en) 2005-11-10
WO2005105832A3 (en) 2006-06-22
JP4689664B2 (ja) 2011-05-25
CA2564179A1 (en) 2005-11-10
TWI353252B (en) 2011-12-01
EP2058328A1 (en) 2009-05-13
KR20070004895A (ko) 2007-01-09
DE602005027502D1 (de) 2011-05-26
AU2005238173B2 (en) 2010-12-23
ES2365084T3 (es) 2011-09-21
ATE505483T1 (de) 2011-04-15
PT2058328E (pt) 2011-07-01
RU2377249C2 (ru) 2009-12-27

Similar Documents

Publication Publication Date Title
EA200700976A1 (ru) Соединения в виде молекул-конъюгатов, обладающих повышенной активностью в отношении включения клеткой
TW200616661A (en) HER2 antibody composition
BRPI0506864A (pt) método para conjugar peptìdeos, peptìdeo conjugado, composto e sais, pró-drogas e solvatos farmaceuticamente aceitáveis destes, composição farmacêutica, uso de um composto, e, método para tratamento de doença
PE20110102A1 (es) Derivados de n-(2-oxo-2-pirrolidinil-1-il)etil-2-amino-acetamida como inhibidores de proteinas de apoptosis (iap)
EE04911B1 (et) Ühend ja farmatseutiline kompositsioon proteaasi inhibiitoritena, nende kasutamine ning meetod selle ühendi valmistamiseks
RU2010111139A (ru) Комбинированная терапия рака поджелудочной железы с использованием антигенного пептида и химиотерапевтического средства
EA200700096A1 (ru) Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии
ATE541582T1 (de) Stabilisierte pharmazeutische glp-1 peptid zusammensetzungen
EA200700380A1 (ru) Конъюгаты глицеринразветвлённого полиэтиленгликоля - гормона роста человека, способ их получения и способы их применения
ATE509634T1 (de) Pharmazeutische formulierungen mit incretin- peptid und aprotisch-polarem lösungsmittel
UY28885A1 (es) 4-fenilamino-quinazolin-6-il-amidas referencia cruzada a solicitud(es) relacionada(s)
TR200200252T2 (tr) Şimerik polipeptidler, bunların üretimi için yöntem ve kullanımı
BRPI0514750A (pt) derivados amida de 7-amino-3-fenil-diidropirimido[4, 5-d]pirimidinonas, sua fabricação e uso como inibidores de proteìna cinase
EA200870599A1 (ru) Стабильные препараты лаквинимода
BR0305628A (pt) Composição farmacêutica para tratar disfunção sexual num mamìfero compreendendo peptìdeo e seu uso
AR066199A1 (es) Metodo para reducir la concentracion del peptido amiloide beta
CY1115629T1 (el) Χρηση ενωσεων πεπτιδιου τρο και φαρμακευτικων συνθεσεων στην θεραπεια της αναιμιας
EE200400031A (et) Biokeemiliste ühendite kompositsioon, selle kasutamine maatriks-metalloproteinaaside pärssimiseks ning seda sisaldav ravimpreparaat
EA200701852A1 (ru) Производные аминокислот
DK2058328T3 (da) Derivater af biologisk aktivt peptid VAPEEHPTLLTEAPLNPK
PE20050285A1 (es) Composicion farmaceutica que comprende analogos ciclicos de somatostatina
ATE465172T1 (de) Peptidträger für die verabreichung von arzneimitteln
SV2003000836A (es) Profarmaco del amino acido estimulantes ref. x-14649
DE602004017062D1 (de) Zusammensetzungen aus deramciclan und opioiden zur verwendung als schmerzmittel
BR0317292A (pt) Derivados de amida de ácido antranìlico e seu uso farmacêutico